Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05162768 |
|---|---|
| Brief Title: | Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) (NuPower) |
| First Submitted : | December 8, 2021 |
| First Submitted that Met QC Criteria : | December 8, 2021 |
| First Posted : | December 17, 2021 |
| Last Update Submitted that Met QC Criteria : | December 9, 2023 |
| Last Update Posted : | December 12, 2023 |